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Abstract
A positron emission tomography scan with fluorodeoxyglucose 
can be affected by several factors. Skeletal muscle activation and 
physiological presence of radioactivity in urine frequently cause 
difficulties in images interpretation. We report a case of a patient 
with a non-operable left lung cancer, who was scheduled for 
FDG PET examination for radiotherapy planning purposes. In the 
first scan performed in the morning both elevated muscular and 
urinary uptake were present. For this reason another examination 
was performed on the same day. A new dose of radiopharma-
ceutical was given five hours after the first FDG injection and the 
patient was instructed to drink a large quantity of water in the 
meantime. The second PET scan clearly revealed two new lesions 
not visible at the time of the first examination: a synchronous blad-
der cancer, previously not known, and a mediastinal metastasis 
of the primary lung cancer. This case emphasizes the importance 
of correct patient preparation and shows the possibility to repeat 
PET examination on the same day.
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Introduction
The quality of a positron emission tomography scan with 
18F-ﬂ uorodeoxyglucose injection (FDG PET) depends highly on 
patient preparation. Meal consumption before FDG PET examination 
is followed by insulin secretion causing extensive uptake of radiophar-
maceutical in skeletal muscle. In consequence, visual interpretation 
is negatively affected. Moreover, the evaluation of the bladder wall 
is usually precluded by physiological FDG excretion in urine if a patient 
has not undergone adequate hydration i.e. has neither drunk water nor 
had intravenous infusion. We report a PET-CT case of a patient with 
lung cancer. Due to the low quality of the ﬁ rst PET scan, the examina-
tion was redone after only 5 hours. This time two important ﬁ nds were 
revealed, namely: synchronous bladder cancer and suspect lymph 
node metastases. They were not visible in the previous scan.
Case report
A 79-year-old male with inoperable non-small cell lung cancer 
of the upper left lobe underwent palliative radiotherapy treatment in 
December 2006. Left hilar adenopathy was detected in a follow-up 
CT examination in March 2012. The patient’s condition deteriorated 
further during the subsequent months and he was referred to FDG 
PET-CT examination in order to possibly schedule second radio-
therapy treatment. That PET-CT was performed in September 2012.
Due to the patient’s clinical condition as well as his age, 
the PET scan was scheduled as the ﬁ rst in the morning. At the 
patient’s arrival his glycemia was measured: 118 mg/ml, and he 
was given an injection of 320 MBq 18F-Fluorodeoxygtlucose at 
8:10. The PET-CT scan was performed at 9:07 with the use of 
Siemens mCT machine. It was performed from the skull base to 
the thigh with time acquisition 120” per bed position. No contrast 
medium was given for CT.
Immediately after the image reconstruction, strong FDG up-
take in skeletal muscle was noticed on MIP projection (Fig. 1A). 
The patient admitted that despite the instruction, he had had 
light breakfast about 1 hour before the examination. Even though 
pathological FDG uptake was observed in the left hilum, the scan 
quality was generally evaluated as non-acceptable.
Taking into account the patient’s disagreement to re-schedule 
the examination, the nuclear medicine specialist decided to redo 
the scan in ﬁ ve hours’ time. The patient was instructed to fast and 
to drink at least 1 liter of water.
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The second injection of 295 MBq of 18-F FDG was performed 
at 13:45. At this time the glycemic level had the value of 96 mg/dl. 
The patient underwent the second PET-CT scan at 14.38 on the 
same scanner. The image quality was evaluated as good (Fig. 1B).
The pathological hot spot on the left pulmonary hilum was con-
ﬁ rmed. After that, faint uptake on a roundish right pre-tracheal lymph 
node, not evident on the ﬁ rst scan, became clearly visible (Fig. 2).
Surprisingly, intense pathological FDG uptake, previously 
completely undetectable, was revealed on the bladder wall. Histo-
pathological examination conﬁ rmed the presence of bladder cancer. 
A radiologically nonspeciﬁ c thickening of the left posterior bladder 
wall was visible in the CT images in both examinations (Fig. 3).
Discussion
Hydration or alternatively diuretic administration allows diluting 
the radioactivity concentration in the urinary tract as they increase 
urine volume. This points to the necessity of implementing several 
protocols for patient preparation, which can signiﬁ cantly improve 
the detection rate of primary bladder malignancy [5–7]. 
Furthermore, increased insulin secretion, due to a non-fasting 
state, interferes with FDG uptake in malignant lesions by increasing 
muscular and cardiac uptake, which leads to altered radiotracer 
biodistribution. The increased avidity of insulin-stimulated muscular 
masses weakens the FDG uptake in cancer sites. Moreover, in 
small lesions — in which the partial volume effect plays a major 
role — the reduced tumor/background ratio can lead to a false 
negative scan [8–10].
Figure 1. MIP projection of the first FDG PET scan (A) and the second 
one (B) performed 5 hours later on the same day
Figure 2. A non enlarged right paratracheal lymph node visible on CT (A, thin arrow) has no FDG uptake at first FDG PET scan (B, thick arrow) but 
showed a pathological activity at second scan (C, dotted arrow)




Figure 3. Bladder wall thickening is visible on CT images of both examinations (A, B, thin arrows). Urinary radioactivity masked this finding at first 
scan (C), conversely an evident pathological FDG uptake is visible on this site after adequate hydration (D, dotted arrow)
Conclusion
The implementation of appropriate patient preparation pro-
cedures for all PET patients plays a pivotal role for obtaining the 
highest possible quality of the scan. It enhances the detection 
rate of small metastases and increases the possibility to visualize 
a metasynchronous malignancy.
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